Page last updated: 2024-08-17

medroxyprogesterone acetate and Carcinoma, Ductal, Breast

medroxyprogesterone acetate has been researched along with Carcinoma, Ductal, Breast in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (42.11)18.2507
2000's9 (47.37)29.6817
2010's2 (10.53)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, AM; Alorro, M; Chand, AL; Clyne, CD; Connelly, AA; Coulson, R; Deb, S; Ernst, M; George, AJ; Hannan, NJ; Harrison, CA; Kumar, B; Lazarus, KA; Liew, SH; Morrow, RJ; O'Toole, SA; Parslow, AC; Poh, A; Putoczki, T; Vargas, AC; Walton, KL; Yeap, EFW; Yee, NS1
Chen, C; Ge, GZ; He, BL; Jiao, JL; Lv, LB; Wang, CY; Xia, HJ; Zhang, HL; Zhang, YX1
Fukushima, M; Ono, Y; Sawada, M1
Fabris, V; Helguero, LA; Lamb, CA; Lanari, C; Lucas, C; Molinolo, AA1
Asaithamby, A; Helguero, LA; Lanari, C; Molinolo, AA; Shyamala, G; Viegas, M1
Mio, H1
Kihara, M; Kontani, K; Yamauchi, A; Yokomise, H1
Beguelin, W; Brouckaert, P; Carnevale, RP; Charreau, EH; Elizalde, PV; Frahm, I; Proietti, CJ; Rivas, MA; Rosemblit, C; Salatino, M; Sapia, S; Schillaci, R1
Hayashi, K; Taniguchi, T; Toi, M; Tominaga, T1
Charreau, EH; Dran, G; Kordon, EC; Lanari, C; Molinolo, AA; Pasqualini, CD; Pazos, P1
Hirata, S; Ikeda, K; Kubo, Y; Maeda, T; Nakajima, S; Sasajima, T; Yamazaki, K1
Andoh, T; Iijima, T; Iino, Y; Inoue, T; Izumi, M; Kobayashi, I; Morishita, Y; Yamada, T; Yokoe, T; Yokota, T1
Daxenbichler, G; Hofstädter, F; Marth, C; Müller-Holzner, E; Zeimet, AG1
Baker, P; Blackledge, GR; Clinton, OP; Dunn, J; Earl, H; Latief, TN; Murphy, A; Priestman, TJ1
Fujii, T; Kanno, K; Ogata, T; Roppongi, T; Yokota, T1
Higashi, Y; Iino, Y; Ishiguro, S; Kurihara, T; Morishita, Y; Suemasu, K; Tabei, T; Takeda, F1
Fabris, V; Helguero, LA; Lamb, CA; Lanari, C; Lüthy, I; Merani, S; Molinolo, AA; Pagano, E; Sanjuan, N1
Akaike, H; Ashizawa, I; Chiba, S; Imamura, K; Mitui, T; Miyauchi, Y; Muto, S; Nakagomi, H; Nakazawa, M; Okuda, J; Takahashi, M1
Hara, Y; Hikosaka, Y; Iwase, H; Kobayashi, S; Toyama, T; Yamashita, H1

Trials

3 trial(s) available for medroxyprogesterone acetate and Carcinoma, Ductal, Breast

ArticleYear
[The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:6

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Administration Schedule; Female; Floxuridine; Humans; Liver Neoplasms; Lung Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Middle Aged; Soft Tissue Neoplasms

1995
[Chemo-endocrine therapy with high dose medroxyprogesterone acetate for recurrent or advanced breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:14

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Rate

1993
A prospective randomized trial to evaluate different oral dose regimens of medroxyprogesterone acetate in women with advanced breast cancer.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1995, Volume: 7, Issue:4

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Drug Administration Schedule; Estrogen Antagonists; Female; Follow-Up Studies; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Progesterone Congeners; Prospective Studies; Remission Induction; Survival Rate; Tamoxifen; Time Factors

1995

Other Studies

16 other study(ies) available for medroxyprogesterone acetate and Carcinoma, Ductal, Breast

ArticleYear
The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
    Oncotarget, 2017, Mar-21, Volume: 8, Issue:12

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiotensin II Type 1 Receptor Blockers; Animals; Biopsy; Breast Neoplasms; Carcinogenesis; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Cell Proliferation; Disease Progression; Female; Humans; Immunohistochemistry; Interleukin-6; Losartan; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Neoplasm Invasiveness; Phosphorylation; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; STAT3 Transcription Factor; Tumor Burden; Tumor Necrosis Factor-alpha; Up-Regulation

2017
PTEN/PIK3CA genes are frequently mutated in spontaneous and medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumours of tree shrews.
    European journal of cancer (Oxford, England : 1990), 2014, Volume: 50, Issue:18

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Disease Models, Animal; Estrogens; Female; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mutation; Papilloma, Intraductal; Phosphatidylinositol 3-Kinase; Progesterone; PTEN Phosphohydrolase; Random Allocation; Receptors, Estrogen; Receptors, Progesterone; Tupaiidae

2014
[A case of advanced recurrent breast cancer responding to treatment with weekly docetaxel combined with doxorubicin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Floxuridine; Humans; Lung Neoplasms; Lymphatic Metastasis; Mastectomy, Modified Radical; Medroxyprogesterone Acetate; Middle Aged; Paclitaxel; Skin Neoplasms; Taxoids

2003
Differential effects of raloxifene, tamoxifen and fulvestrant on a murine mammary carcinoma.
    Breast cancer research and treatment, 2003, Volume: 79, Issue:1

    Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Chorionic Gonadotropin, beta Subunit, Human; Estradiol; Estrogen Receptor Modulators; Female; Medroxyprogesterone Acetate; Melitten; Mice; Mice, Inbred BALB C; Raloxifene Hydrochloride; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured

2003
Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment.
    Breast cancer research and treatment, 2003, Volume: 79, Issue:3

    Topics: Animals; Blotting, Western; Carcinoma, Ductal, Breast; Down-Regulation; Estrogens; Female; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Progesterone Congeners; Progestins; Receptors, Progesterone; RNA

2003
[A case of postoperative recurrent breast cancer with multiple lung metastases that completely responded to combination therapy of docetaxel (TXT) and medroxyprogesterone acetate (MPA)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Mastectomy, Modified Radical; Medroxyprogesterone Acetate; Middle Aged; Paclitaxel; Postoperative Period; Remission Induction; Taxoids

2003
[Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:5

    Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged

2005
TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
    Experimental cell research, 2008, Feb-01, Volume: 314, Issue:3

    Topics: Animals; Apoptosis Regulatory Proteins; Carcinogens; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Proliferation; Female; Humans; JNK Mitogen-Activated Protein Kinases; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasms, Hormone-Dependent; NF-kappa B; Nitriles; Proto-Oncogene Proteins c-akt; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Sulfones; Transcriptional Activation; Tumor Necrosis Factor-alpha

2008
Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology.
    Breast cancer research and treatment, 1993, Volume: 28, Issue:1

    Topics: Adenocarcinoma; Animals; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasms, Hormone-Dependent; Progesterone; Progestins; Receptors, Estrogen; Receptors, Progesterone

1993
[Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Doxorubicin; Drug Administration Schedule; Drug Resistance; Female; Humans; Medroxyprogesterone Acetate; Mitoxantrone

1994
Effects of sex- and glucocorticoid steroids on breast cancer cells grown as either multicellular tumor spheroids or monolayers.
    The Journal of steroid biochemistry and molecular biology, 1996, Volume: 58, Issue:1

    Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Dexamethasone; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Humans; Medroxyprogesterone Acetate; Mifepristone; Spheroids, Cellular; Steroids; Tamoxifen; Tumor Cells, Cultured

1996
[A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:5

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged

1998
Multidrug-resistant recurrent breast cancer which responded to medroxyprogesterone acetate showing a remarkable improvement in the quality of life: report of a case and the role of team medical care.
    Surgery today, 1998, Volume: 28, Issue:9

    Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Palliative Care; Patient Care Team; Quality of Life

1998
Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
    Cancer research, 2001, Jan-01, Volume: 61, Issue:1

    Topics: Animals; Carcinoma, Ductal, Breast; Cell Differentiation; Cell Division; Disease Models, Animal; Estradiol; Female; Immunohistochemistry; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Microscopy, Electron; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured

2001
[A patient with recurrent breast cancer whose liver metastasis regressed following combined use of weekly docetaxel and MPA.5'-DFUR].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Paclitaxel; Taxoids

2001
Successful management of breast cancer with liver metastases with medroxyprogesterone acetate treatment.
    International journal of clinical oncology, 2001, Volume: 6, Issue:6

    Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Tomography, X-Ray Computed; Treatment Outcome

2001